Anna A. Penn

Dr. Anna A. Penn


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2021 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
CVClaire Marie Vacher
Claire Marie Vacher
HLHelene Lacaille
Helene Lacaille
JOJiaqi J. O’rEilly
Jiaqi J. O’rEilly
JSJacquelyn Salzbank
Jacquelyn Salzbank
DBDana Bakalar
Dana Bakalar
APAnna A. Penn
Anna A. Penn
Compromised placental function or premature loss has been linked to diverse neurodevelopmental disorders. Here we show that placenta allopregnanolone (ALLO), a progesterone-derived GABA-A receptor (GABAAR) modulator, reduction alters neurodevelopment in a sex-linked manner. A new conditional mouse model, in which the gene encoding ALLO’s synthetic enzyme (akr1c14) is specifically deleted in trophoblasts, directly demonstrated that placental ALLO insufficiency led to cerebellar white matter abnormalities that correlated with autistic-like behavior only in male offspring. A single injection of ALLO or muscimol, a GABAAR agonist, during late gestation abolished these alterations. Comparison of male and female human preterm infant cerebellum also showed sex-linked myelination marker alteration, suggesting similarities between mouse placental ALLO insufficiency and human preterm brain development. This study reveals a new role for a placental hormone in shaping brain regions and behaviors in a sex-linked manner. Placental hormone replacement might offer novel therapeutic opportunities to prevent later neurobehavioral disorders.

1 August 2021 in Seminars in Fetal and Neonatal Medicine
Verified
Journal Article
Closed access
APAnna A. Penn
Anna A. Penn
PWP. Wintermark
P. Wintermark
LCL.F. Chalak
L.F. Chalak
JAJ. Armstrong
J. Armstrong
RRR. Redline
R. Redline
KNK.B. Nelson
K.B. Nelson

26 July 2012 in Journal of Perinatology
Verified
Journal Article
Closed access
MGMara Greenberg
Mara Greenberg
APAnna A. Penn
Anna A. Penn
KWK R Whitaker
K R Whitaker
EKE A Kogut
E A Kogut
YEY Y El-Sayed
Y Y El-Sayed
DLD J Lyell
D J Lyell

13 October 2022 in Frontiers in Endocrinology
Verified
Journal Article
Open access
DBDana Bakalar
Dana Bakalar
JOJiaqi J. O’rEilly
Jiaqi J. O’rEilly
HLHelene Lacaille
Helene Lacaille
JSJacquelyn Salzbank
Jacquelyn Salzbank
JEJacob Ellegood
Jacob Ellegood
APAnna A. Penn
Anna A. Penn
Placental endocrine function is essential to fetal brain development. Placental hormones include neurosteroids such as allopregnanolone (ALLO), a regulator of neurodevelopmental processesviapositive allosteric modulation of the GABAAreceptor (GABAA-R). Using a mouse model (plKO) in which the gene encoding the ALLO synthesis enzyme is specifically deleted in trophoblasts, we previously showed that placental ALLO insufficiency alters cerebellar white matter development and leads to male-specific autistic-like behavior. We now demonstrate that the lack of placental ALLO causes female-predominant alterations of cortical development and function. Placental ALLO insufficiency disrupts cell proliferation in the primary somatosensory cortex (S1) in a sex-linked manner. Early changes are seen in plKO embryos of both sexes, but persist primarily in female offspring after birth. Adolescent plKO females show significant reduction in pyramidal neuron density, as well as somatosensory behavioral deficits as compared with plKO males and control littermates. Assessment of layer-specific markers in human postmortem cortices suggests that preterm infants may also have female-biased abnormalities in cortical layer specification as compared with term infants. This study establishes a novel and fundamental link between placental function and sex-linked long-term neurological outcomes, emphasizing the importance of the growing field of neuroplacentology.

3 February 2022 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
HLHelene Lacaille
Helene Lacaille
CVClaire-Marie Vacher
Claire-Marie Vacher
APAnna A. Penn
Anna A. Penn
Developmental changes in GABAergic and glutamatergic systems during frontal lobe development have been hypothesized to play a key role in neurodevelopmental disorders seen in children born very preterm or at/with low birth weight, but the associated cellular changes have not yet been identified. Here we studied the molecular development of the GABAergic system specifically in the dorsolateral prefrontal cortex, a region that has been implicated in neurodevelopmental and psychiatric disorders. The maturation state of the GABAergic system in this region was assessed in human post-mortem brain samples, from term infants ranging in age from 0 to 8 months (n= 17 male, 9 female). Gene expression was measured for 47 GABAergic genes and used to calculate a maturation index. This maturation index was significantly more dynamic in male than female infants. To evaluate the impact of premature birth on the GABAergic system development, samples from 1-month-old term (n= 9 male, 4 female) and 1-month corrected-age very preterm (n= 8 male, 6 female) infants, were compared using the same gene list and methodology. The maturation index for the GABAergic system was significantly lower (−50%,p< 0.05) in male preterm infants, with major alterations in genes linked to GABAergic function in astrocytes, suggesting astrocytic GABAergic developmental changes as a new cellular mechanism underlying preterm brain injury.

9 January 2025 in Journal of Neuroendocrinology
Verified
Journal Article
Open access
CVClaire Marie Vacher
Claire Marie Vacher
ATAlex Tsompanidis
Alex Tsompanidis
MFMorgan R. Firestein
Morgan R. Firestein
APAnna A. Penn
Anna A. Penn
The placenta is a fetal endocrine organ that secretes many neuroactive factors, including steroids, that play critical roles in brain development. The study of the placenta‐brain axis and the links between placental function and brain development represents an emerging research area dubbed “neuroplacentology.” The placenta drives many circulating fetal steroids to very high levels during gestation. Recent studies have highlighted the critical role of placental steroids in shaping specific brain structures and behaviors. This review uses a cross‐species framework to discuss the genomic factors, in‐utero environmental changes, and placental conditions that alter placental steroidogenesis, leading to changes in early developmental trajectories relevant for psychiatric conditions such as autism, in a sex‐linked manner.